Age-dependent risk of respiratory syncytial virus infection: A systematic review and hazard modeling from serological data
K Nakajo, H Nishiura - The Journal of Infectious Diseases, 2023 - academic.oup.com
Background There is no immunization campaign that currently exist for respiratory syncytial
virus (RSV). Seroprevalence studies are critical for assessing epidemiological dynamics …
virus (RSV). Seroprevalence studies are critical for assessing epidemiological dynamics …
Disease burden due to respiratory syncytial virus in Indian pediatric population: A literature review
C Ghia, G Rambhad - Clinical Medicine Insights: Pediatrics, 2021 - journals.sagepub.com
Respiratory syncytial virus (RSV) is one of the leading causes of lower respiratory tract
infections in young children. Globally, there is huge disease burden, high treatment cost …
infections in young children. Globally, there is huge disease burden, high treatment cost …
[HTML][HTML] High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in …
S Pasittungkul, I Thongpan, P Vichaiwattana… - International Journal of …, 2022 - Elsevier
Objectives To investigate the seroprevalence of respiratory syncytial virus (RSV) infections
in young children, the correlation between RSV antibody levels in maternal and cord serum …
in young children, the correlation between RSV antibody levels in maternal and cord serum …
A candidate therapeutic monoclonal antibody inhibits both HRSV and HMPV replication in mice
H Fausther-Bovendo, ME Hamelin, J Carbonneau… - Biomedicines, 2022 - mdpi.com
Human metapneumovirus (HMPV) and human respiratory virus (HRSV) are two leading
causes of acute respiratory tract infection in young children. While there is no licensed drug …
causes of acute respiratory tract infection in young children. While there is no licensed drug …
Challenges in the prevention or treatment of RSV with emerging new agents in children from low-and middle-income countries
X Carbonell-Estrany, BS Rodgers-Gray… - Expert Review of Anti …, 2021 - Taylor & Francis
Introduction Respiratory syncytial virus (RSV) causes approximately 120,000 deaths
annually in children< 5 years, with 99% of fatalities occurring in low-and middle-income …
annually in children< 5 years, with 99% of fatalities occurring in low-and middle-income …
Antibody responses to respiratory syncytial virus: A population-based cross-sectional serological study in southern China, 2021
Q Wang, N Liu, Y Wang, TJ Ruckwardt, M Xu… - Clinical Microbiology …, 2024 - Elsevier
Objectives With remarkable progress in the field of RSV prophylaxis, it is critical to
understand population immunity against RSV. We aim to describe the RSV pre-F …
understand population immunity against RSV. We aim to describe the RSV pre-F …
Evaluation of respiratory syncytial virus IgG antibody dynamics in mother-infant pairs cohort
RSV is one of the most important agents of lower respiratory infections in childhood. In this
study, anti-RSV antibody levels in mother-infant pairs and factors related to antibody transfer …
study, anti-RSV antibody levels in mother-infant pairs and factors related to antibody transfer …
[PDF][PDF] Respiratory Syncytial Virus
M Surendranath - Pediatric Infectious Disease, 2020 - pidjournal.com
Respiratory syncytial virus (RSV) is one of most common cause of lower respiratory tract
infection in infants less than 2 years of age and sometimes in elderly people. Bronchiolitis is …
infection in infants less than 2 years of age and sometimes in elderly people. Bronchiolitis is …
[PDF][PDF] Respiratory Syncytial Virus and Influenza Virus Co-Infection in the Era of COVID-19 Pandemic
Abstract Background: Respiratory Syncytial Virus (RSV), a known viral pathogen of pediatric
age group is now an emerging cause of severe respiratory illness in adults. Human …
age group is now an emerging cause of severe respiratory illness in adults. Human …